These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37490345)

  • 1. Argininosuccinate lyase deficiency causes blood-brain barrier disruption via nitric oxide-mediated dysregulation of claudin expression.
    Kho J; Polak U; Jiang MM; Odom JD; Hunter JV; Ali SM; Burrage LC; Nagamani SC; Pautler RG; Thompson HP; Urayama A; Jin Z; Lee B
    JCI Insight; 2023 Sep; 8(17):. PubMed ID: 37490345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Requirement of argininosuccinate lyase for systemic nitric oxide production.
    Erez A; Nagamani SC; Shchelochkov OA; Premkumar MH; Campeau PM; Chen Y; Garg HK; Li L; Mian A; Bertin TK; Black JO; Zeng H; Tang Y; Reddy AK; Summar M; O'Brien WE; Harrison DG; Mitch WE; Marini JC; Aschner JL; Bryan NS; Lee B
    Nat Med; 2011 Nov; 17(12):1619-26. PubMed ID: 22081021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitric oxide modulates bone anabolism through regulation of osteoblast glycolysis and differentiation.
    Jin Z; Kho J; Dawson B; Jiang MM; Chen Y; Ali S; Burrage LC; Grover M; Palmer DJ; Turner DL; Ng P; Nagamani SC; Lee B
    J Clin Invest; 2021 Mar; 131(5):. PubMed ID: 33373331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Argininosuccinate Lyase Deficiency Causes an Endothelial-Dependent Form of Hypertension.
    Kho J; Tian X; Wong WT; Bertin T; Jiang MM; Chen S; Jin Z; Shchelochkov OA; Burrage LC; Reddy AK; Jiang H; Abo-Zahrah R; Ma S; Zhang P; Bissig KD; Kim JJ; Devaraj S; Rodney GG; Erez A; Bryan NS; Nagamani SCS; Lee BH
    Am J Hum Genet; 2018 Aug; 103(2):276-287. PubMed ID: 30075114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Argininosuccinate lyase deficiency-argininosuccinic aciduria and beyond.
    Erez A; Nagamani SC; Lee B
    Am J Med Genet C Semin Med Genet; 2011 Feb; 157C(1):45-53. PubMed ID: 21312326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitric oxide is required for lung alveolarization revealed by deficiency of argininosuccinate lyase.
    Jin Z; Jiang MM; Lee B
    Hum Mol Genet; 2023 Dec; 33(1):33-37. PubMed ID: 37738569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Argininosuccinate neurotoxicity and prevention by creatine in argininosuccinate lyase deficiency: An in vitro study in rat three-dimensional organotypic brain cell cultures.
    Diez-Fernandez C; Hertig D; Loup M; Diserens G; Henry H; Vermathen P; Nuoffer JM; Häberle J; Braissant O
    J Inherit Metab Dis; 2019 Nov; 42(6):1077-1087. PubMed ID: 30907007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Argininosuccinate lyase deficiency.
    Nagamani SC; Erez A; Lee B
    Genet Med; 2012 May; 14(5):501-7. PubMed ID: 22241104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitric-oxide supplementation for treatment of long-term complications in argininosuccinic aciduria.
    Nagamani SC; Campeau PM; Shchelochkov OA; Premkumar MH; Guse K; Brunetti-Pierri N; Chen Y; Sun Q; Tang Y; Palmer D; Reddy AK; Li L; Slesnick TC; Feig DI; Caudle S; Harrison D; Salviati L; Marini JC; Bryan NS; Erez A; Lee B
    Am J Hum Genet; 2012 May; 90(5):836-46. PubMed ID: 22541557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations and polymorphisms in the human argininosuccinate lyase (ASL) gene.
    Balmer C; Pandey AV; Rüfenacht V; Nuoffer JM; Fang P; Wong LJ; Häberle J
    Hum Mutat; 2014 Jan; 35(1):27-35. PubMed ID: 24166829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural history of epilepsy in argininosuccinic aciduria provides new insights into pathophysiology: A retrospective international study.
    Elkhateeb N; Olivieri G; Siri B; Boyd S; Stepien KM; Sharma R; Morris AAM; Hartley T; Crowther L; Grunewald S; Cleary M; Mundy H; Chakrapani A; Lachmann R; Murphy E; Santra S; Uudelepp ML; Yeo M; Bernhardt I; Sudakhar S; Chan A; Mills P; Ridout D; Gissen P; Dionisi-Vici C; Baruteau J
    Epilepsia; 2023 Jun; 64(6):1612-1626. PubMed ID: 36994644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Argininosuccinic aciduria fosters neuronal nitrosative stress reversed by Asl gene transfer.
    Baruteau J; Perocheau DP; Hanley J; Lorvellec M; Rocha-Ferreira E; Karda R; Ng J; Suff N; Diaz JA; Rahim AA; Hughes MP; Banushi B; Prunty H; Hristova M; Ridout DA; Virasami A; Heales S; Howe SJ; Buckley SMK; Mills PB; Gissen P; Waddington SN
    Nat Commun; 2018 Aug; 9(1):3505. PubMed ID: 30158522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unstable argininosuccinate lyase in variant forms of the urea cycle disorder argininosuccinic aciduria.
    Hu L; Pandey AV; Balmer C; Eggimann S; Rüfenacht V; Nuoffer JM; Häberle J
    J Inherit Metab Dis; 2015 Sep; 38(5):815-27. PubMed ID: 25778938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic and functional correction of argininosuccinate lyase deficiency using CRISPR adenine base editors.
    Jalil S; Keskinen T; Juutila J; Sartori Maldonado R; Euro L; Suomalainen A; Lapatto R; Kuuluvainen E; Hietakangas V; Otonkoski T; Hyvönen ME; Wartiovaara K
    Am J Hum Genet; 2024 Apr; 111(4):714-728. PubMed ID: 38579669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RGMa Participates in the Blood-Brain Barrier Dysfunction Through BMP/BMPR/YAP Signaling in Multiple Sclerosis.
    Zhang L; Tang S; Ma Y; Liu J; Monnier P; Li H; Zhang R; Yu G; Zhang M; Li Y; Feng J; Qin X
    Front Immunol; 2022; 13():861486. PubMed ID: 35664003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemoglobin-induced nitric oxide synthase overexpression and nitric oxide production contribute to blood-brain barrier disruption in the rat.
    Yang S; Chen Y; Deng X; Jiang W; Li B; Fu Z; Du M; Ding R
    J Mol Neurosci; 2013 Oct; 51(2):352-63. PubMed ID: 23494638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimizing therapy for argininosuccinic aciduria.
    Nagamani SC; Lee B; Erez A
    Mol Genet Metab; 2012 Sep; 107(1-2):10-4. PubMed ID: 22841516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simvastatin, edaravone and dexamethasone protect against kainate-induced brain endothelial cell damage.
    Barna L; Walter FR; Harazin A; Bocsik A; Kincses A; Tubak V; Jósvay K; Zvara Á; Campos-Bedolla P; Deli MA
    Fluids Barriers CNS; 2020 Feb; 17(1):5. PubMed ID: 32036791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Argininosuccinic aciduria: Recent pathophysiological insights and therapeutic prospects.
    Baruteau J; Diez-Fernandez C; Lerner S; Ranucci G; Gissen P; Dionisi-Vici C; Nagamani S; Erez A; Häberle J
    J Inherit Metab Dis; 2019 Nov; 42(6):1147-1161. PubMed ID: 30723942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. mRNA therapy corrects defective glutathione metabolism and restores ureagenesis in preclinical argininosuccinic aciduria.
    Gurung S; Timmermand OV; Perocheau D; Gil-Martinez AL; Minnion M; Touramanidou L; Fang S; Messina M; Khalil Y; Spiewak J; Barber AR; Edwards RS; Pinto PL; Finn PF; Cavedon A; Siddiqui S; Rice L; Martini PGV; Ridout D; Heywood W; Hargreaves I; Heales S; Mills PB; Waddington SN; Gissen P; Eaton S; Ryten M; Feelisch M; Frassetto A; Witney TH; Baruteau J
    Sci Transl Med; 2024 Jan; 16(729):eadh1334. PubMed ID: 38198573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.